Unknown

Dataset Information

0

Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021.

ABSTRACT:

SUBMITTER: Tabak YP 

PROVIDER: S-EPMC8696565 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021.

Tabak Ying P YP   Sun Xiaowu X   Brennan Troyen A TA   Chaguturu Sreekanth K SK  

JAMA network open 20211201 12

Similar Datasets

Unknown Vaccine effectiveness against COVID-19 among symptomatic persons aged ≥12 years with reported contact with COVID-19 cases, February-September 2021.
| S-EPMC9111783 | biostudies-literature
Unknown Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022.
| S-EPMC10169571 | biostudies-literature
Unknown Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021.
| S-EPMC8414959 | biostudies-literature
Unknown Transmission Dynamics and Effectiveness of Control Measures during COVID-19 Surge, Taiwan, April-August 2021.
| S-EPMC9514361 | biostudies-literature
Unknown Answer to August 2021 Photo Quiz.
| S-EPMC8373207 | biostudies-literature
Unknown Self-reported mask use among persons with or without SARS CoV-2 vaccination -United States, December 2020-August 2021.
| S-EPMC9181355 | biostudies-literature
Unknown Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.
| S-EPMC9500552 | biostudies-literature
Unknown Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021.
| S-EPMC8485582 | biostudies-literature
Unknown Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021.
| S-EPMC9744684 | biostudies-literature
Unknown Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
| S-EPMC9995303 | biostudies-literature